Unknown

Dataset Information

0

The D-dimer level predicts the postoperative prognosis in patients with non-small cell lung cancer.


ABSTRACT: BACKGROUND:Carcinoma cells often modulate coagulation and fibrinolysis among cancer patients. Plasma dimerized plasmin fragment D (D-dimer) has been reported as a prognostic marker of various types of malignancies, including non-small cell lung cancer (NSCLC). However, the associations between the plasma D-dimer level and peripheral small NSCLC remain unclear. METHODS:Three hundred and sixty-two patients with NSCLC who underwent radical surgery were retrospectively reviewed. Patients who received anticoagulation therapy before surgery or who lacked preoperative D-dimer data were excluded. The other 235 patients were divided into a high D-dimer (over 1.0 ?g/mL) group (HDD group, n = 47) and a normal D-dimer group (NDD group, n = 188) and investigated for their clinical characteristics, computed tomography (CT) findings, pathological findings, and clinical outcomes. RESULTS:The mean D-dimer levels was 2.49±2.58 ?g/ml in the HDD group and 0.42±0.23 ?g/ml in the NDD group. The HDD group was characterized by a predominance of male gender, older age, pure solid appearance on chest CT, vascular invasion in pathology, and a large solid part of the tumor. The HDD group showed a worse overall survival, disease-free survival, and disease-specific survival than the NDD group (p<0.001, <0.001, <0.001, respectively). These survival features were also observed in p-Stage IA disease. There was no marked survival difference when tumors showed ground-glass opacity on CT. CONCLUSION:In NSCLC patients with a solid tumor appearance on CT, high D-dimer levels predict a poor survival and early recurrence.

SUBMITTER: Shiina Y 

PROVIDER: S-EPMC6932866 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

The D-dimer level predicts the postoperative prognosis in patients with non-small cell lung cancer.

Shiina Yuki Y   Nakajima Takahiro T   Yamamoto Takayoshi T   Tanaka Kazuhisa K   Sakairi Yuichi Y   Wada Hironobu H   Suzuki Hidemi H   Yoshino Ichiro I  

PloS one 20191226 12


<h4>Background</h4>Carcinoma cells often modulate coagulation and fibrinolysis among cancer patients. Plasma dimerized plasmin fragment D (D-dimer) has been reported as a prognostic marker of various types of malignancies, including non-small cell lung cancer (NSCLC). However, the associations between the plasma D-dimer level and peripheral small NSCLC remain unclear.<h4>Methods</h4>Three hundred and sixty-two patients with NSCLC who underwent radical surgery were retrospectively reviewed. Patie  ...[more]

Similar Datasets

| S-EPMC3264655 | biostudies-literature
| S-EPMC5444728 | biostudies-literature
| S-EPMC5549961 | biostudies-other
| S-EPMC8339854 | biostudies-literature
| S-EPMC8226084 | biostudies-literature
| S-EPMC8399789 | biostudies-literature
| S-EPMC7481597 | biostudies-literature
| S-EPMC6266348 | biostudies-literature
| S-EPMC3790190 | biostudies-other
| S-EPMC7471045 | biostudies-literature